HIMS logo

HIMS

Hims & Hers Health Inc. Class A

$27.35
+$3.05(+12.58%)
34
Overall
20
Value
20
Tech
63
Quality
How is this score calculated?
Market Cap
$9.60B
Volume
69.81M
52W Range
$13.74 - $70.43
Target Price
$25.31

Company Overview

Mkt Cap$9.60BPrice$27.35
Volume69.81MChange+12.58%
P/E Ratio76.2Open$26.15
Revenue$1.5BPrev Close$24.29
Net Income$126.0M52W Range$13.74 - $70.43
Div YieldN/ATarget$25.31
Overall34Value20
Quality63Technical20

No chart data available

About Hims & Hers Health Inc. Class A

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector: Healthcare
Industry: Offices of Physicians, Mental Health Specialists

Latest News

Hims & Hers Stock Boosts on FDA Peptide Review, Leerink Analyst Calls Move a “Clear Positive”

Hims & Hers Health ($HIMS) stock jumped 10.1% on Wednesday after the FDA announced a review of several injectable peptides. Following the news, Lee...

Radhika Saraogi9 hours ago

Morning News Wrap-Up, 4/16/26: Today’s Biggest Stock Market Stories!

William White9 hours ago

Hims & Hers Stock Boosts on FDA Peptide Review, Leerink Analyst Calls Move a “Clear Positive”

Radhika Saraogi10 hours ago

Morning News Wrap-Up, 4/16/26: Today’s Biggest Stock Market Stories!

William White10 hours ago

Hims & Hers Health (HIMS) Gets a Hold from Bank of America Securities

TipRanks Auto-Generated Intelligence Newsdesk17 hours ago
ABCD
1SymbolPriceChangeVol
2HIMS$27.35+12.6%69.81M
3
4
5
6

Get Hims & Hers Health Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.